MSC isolation and adherent expansion
Materials Required
Principle
Mesenchymal stromal/stem cells are isolated by their ability to adhere to tissue-culture plastic, expand as fibroblast-like colonies, and retain defined MSC identity after expansion; the accepted identity readout is plastic adherence, expression of CD105/CD73/CD90, absence of major hematopoietic markers including CD45/CD34/CD14 or CD11b/CD79α or CD19/HLA-DR, and in-vitro osteogenic, adipogenic, and chondrogenic differentiation.
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Collagenase-based digestion is used for adipose-derived stromal vascular fraction or umbilical cord matrix methods when enzymatic isolation is selected.
• Use flow-cytometry antibodies for CD105, CD73, CD90, CD45, CD34, CD14 or CD11b, CD79α or CD19, and HLA-DR to confirm MSC phenotype, and use lineage-differentiation staining readouts for osteogenic, adipogenic, and chondrogenic induction when identity confirmation is required.
• Use sterile tissue-culture plasticware for adherence-based selection, a biosafety cabinet and CO2 incubator for aseptic mammalian-cell culture, a centrifuge for cell recovery and washing, an inverted microscope for morphology and confluence monitoring, and a flow cytometer for immunophenotyping.
Experimental Procedure
• Bone marrow mononuclear or whole marrow preparations can be plated for adherence-based MSC recovery, adipose tissue can be enzymatically processed to obtain stromal vascular fraction before adherent culture, and umbilical cord matrix can be processed by explant or enzymatic methods before adherent expansion.
• Prepare complete culture medium using the serum-supplemented conditions reported in the selected protocol paper, and pre-equilibrate medium before plating cells when routine mammalian-cell culture conditions are used.
• Plate the prepared cell suspension or tissue-derived fraction onto tissue-culture plastic and maintain cultures under standard MSC culture conditions so that non-adherent hematopoietic or debris-containing fractions can be removed during medium changes while adherent fibroblast-like colonies are retained.
• Replace medium during primary culture to remove non-adherent cells;
• In the mouse bone-marrow protocol, frequent medium changes and minimized trypsinization time were highlighted as core features for MSC isolation and culture.
• Expand adherent cells as a monolayer and passage before overgrowth when cells reach the confluence range used in the selected protocol;
• Lower plating density and shorter passage duration were reported to improve expansion yield and preservation of early progenitor features in human bone-marrow stromal cultures.
• For adipose-derived MSCs, digest adipose tissue to obtain stromal vascular fraction, culture the adherent fraction, and expand cells through serial passaging before characterization by morphology, immunophenotype, and differentiation assays.
• For umbilical cord matrix MSCs, either explant-based or enzymatic isolation can generate adherent MSC-like cells, and one comparative study found that a 10-mm tissue explant approach gave shorter primary-culture time, higher cell number, and higher proliferation than other tested umbilical cord matrix methods.
• Assess successful isolation by the appearance of adherent fibroblast-like colonies and expansion into a monolayer, then confirm MSC identity using the ISCT minimal criteria: positive CD105/CD73/CD90, negative hematopoietic-lineage markers, and in-vitro differentiation into osteoblasts, adipocytes, and chondroblasts.
• Compare cultures by passage number, morphology, expansion rate, and immunophenotype, because tissue source, isolation method, serum supplement, seeding density, and passage conditions can alter MSC yield and culture quality.
Troubleshooting
Low recovery of adherent MSC colonies:
Possible CauseSource material or isolation method yields few colony-forming adherent progenitors.
Solution
Use adherence-based selection with medium changes for marrow cultures, consider stromal vascular fraction processing for adipose tissue, and consider the 10-mm explant method for umbilical cord matrix when that source is used.
Reduced expansion or loss of early progenitor features during culture:
Possible CausePassage conditions, plating density, and prolonged culture can affect yield and culture quality.
Solution
Use lower plating density and shorter passage duration when following human bone-marrow stromal expansion conditions designed to maximize early progenitor yield.
Culture cannot be classified as MSC after expansion:
Possible CauseThe adherent culture may contain non-MSC populations or incompletely characterized cells.
Solution
Do not classify the culture as MSC unless it meets plastic adherence, surface-marker, and tri-lineage differentiation criteria.
References:
- [1]. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. [Content Brief]
- [2]. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147. [Content Brief]
- [3]. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luriá EA, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2(2):83-92. [Content Brief]
- [4]. Soleimani M, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009;4(1):102-106. [Content Brief]
- [5]. Sekiya I, et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002;20(6):530-541. [Content Brief]
- [6]. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228. [Content Brief]
- [7]. Bunnell BA, et al. Adipose-derived stem cells: isolation, expansion and differentiation. Methods. 2008;45(2):115-120. [Content Brief]
- [8]. Hua J, Gong J, Meng H, Xu B, Yao L, Qian M, et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell Biol Int. 2014;38(2):198-210. [Content Brief]